Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRC-001 for Aromatase Inhibitor-Induced Arthralgia in Breast Cancer
NCT06538389Phase 2Suspended
- Sponsor
- City of Hope
- Start
- Aug 2024
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in aromatase inhibitor-induced arthralgia (AIA) comparing Arm I (BRC-001) with Arm II (Placebo) (2 arms). Primary endpoint: Brief Pain Inventory-Short Form score. Started Aug 2024; status: suspended.
02
Drugs
BRC-001
03
Conditions
aromatase inhibitor-induced arthralgia (AIA)
Beyond the preview
Go deeper on NCT06538389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06538389.